In vitro and in vivo production and purification of circular RNA aptamer

So Umekage, Yo Kikuchi

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

RNA aptamers are potential candidates for RNA therapeutics. They must be clinically modified for medical applications because they are vulnerable to indigenous ribonucleases. Since circular RNA molecules without any chemical modification are much more stable than linear ones in a cell extract, we report the production of a circular form of streptavidin RNA aptamer both in vitro and in vivo. Circularization was accomplished by self-splicing permuted intron-exon sequences derived from T4 bacteriophage gene td. This sequence was producible in both Escherichia coli cells and in vitro. The circularized streptavidin RNA aptamer retained its binding of streptavidin and was stabile in HeLa cell extracts compared to the linear form of the streptavidin aptamer. The self-spliced circular RNA from the transcribed permuted intron-exon transcripts in E. coli cells was purified from a total RNA fraction using the solid-phase DNA probe method following anion exchange chromatography that excluded gel electrophoresis. This study provides an alternative method for designing and purifying useful RNA aptamers.

Original languageEnglish
Pages (from-to)265-272
Number of pages8
JournalJournal of Biotechnology
Volume139
Issue number4
DOIs
Publication statusPublished - 2009 Feb 23
Externally publishedYes

Fingerprint

Nucleotide Aptamers
Streptavidin
RNA
Purification
Cell Extracts
Introns
Escherichia coli
Exons
Bacteriophage T4
Bacteriophages
DNA Probes
Chemical modification
Medical applications
Ribonucleases
Chromatography
Electrophoresis
HeLa Cells
Gel Chromatography
Anions
Genes

Keywords

  • Circular RNA aptamer
  • In vivo expression
  • Self-splicing
  • Solid-phase DNA probe method

ASJC Scopus subject areas

  • Biotechnology
  • Applied Microbiology and Biotechnology

Cite this

In vitro and in vivo production and purification of circular RNA aptamer. / Umekage, So; Kikuchi, Yo.

In: Journal of Biotechnology, Vol. 139, No. 4, 23.02.2009, p. 265-272.

Research output: Contribution to journalArticle

Umekage, So ; Kikuchi, Yo. / In vitro and in vivo production and purification of circular RNA aptamer. In: Journal of Biotechnology. 2009 ; Vol. 139, No. 4. pp. 265-272.
@article{f3a4511864f54899969395996d314f9b,
title = "In vitro and in vivo production and purification of circular RNA aptamer",
abstract = "RNA aptamers are potential candidates for RNA therapeutics. They must be clinically modified for medical applications because they are vulnerable to indigenous ribonucleases. Since circular RNA molecules without any chemical modification are much more stable than linear ones in a cell extract, we report the production of a circular form of streptavidin RNA aptamer both in vitro and in vivo. Circularization was accomplished by self-splicing permuted intron-exon sequences derived from T4 bacteriophage gene td. This sequence was producible in both Escherichia coli cells and in vitro. The circularized streptavidin RNA aptamer retained its binding of streptavidin and was stabile in HeLa cell extracts compared to the linear form of the streptavidin aptamer. The self-spliced circular RNA from the transcribed permuted intron-exon transcripts in E. coli cells was purified from a total RNA fraction using the solid-phase DNA probe method following anion exchange chromatography that excluded gel electrophoresis. This study provides an alternative method for designing and purifying useful RNA aptamers.",
keywords = "Circular RNA aptamer, In vivo expression, Self-splicing, Solid-phase DNA probe method",
author = "So Umekage and Yo Kikuchi",
year = "2009",
month = "2",
day = "23",
doi = "10.1016/j.jbiotec.2008.12.012",
language = "English",
volume = "139",
pages = "265--272",
journal = "Journal of Biotechnology",
issn = "0168-1656",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - In vitro and in vivo production and purification of circular RNA aptamer

AU - Umekage, So

AU - Kikuchi, Yo

PY - 2009/2/23

Y1 - 2009/2/23

N2 - RNA aptamers are potential candidates for RNA therapeutics. They must be clinically modified for medical applications because they are vulnerable to indigenous ribonucleases. Since circular RNA molecules without any chemical modification are much more stable than linear ones in a cell extract, we report the production of a circular form of streptavidin RNA aptamer both in vitro and in vivo. Circularization was accomplished by self-splicing permuted intron-exon sequences derived from T4 bacteriophage gene td. This sequence was producible in both Escherichia coli cells and in vitro. The circularized streptavidin RNA aptamer retained its binding of streptavidin and was stabile in HeLa cell extracts compared to the linear form of the streptavidin aptamer. The self-spliced circular RNA from the transcribed permuted intron-exon transcripts in E. coli cells was purified from a total RNA fraction using the solid-phase DNA probe method following anion exchange chromatography that excluded gel electrophoresis. This study provides an alternative method for designing and purifying useful RNA aptamers.

AB - RNA aptamers are potential candidates for RNA therapeutics. They must be clinically modified for medical applications because they are vulnerable to indigenous ribonucleases. Since circular RNA molecules without any chemical modification are much more stable than linear ones in a cell extract, we report the production of a circular form of streptavidin RNA aptamer both in vitro and in vivo. Circularization was accomplished by self-splicing permuted intron-exon sequences derived from T4 bacteriophage gene td. This sequence was producible in both Escherichia coli cells and in vitro. The circularized streptavidin RNA aptamer retained its binding of streptavidin and was stabile in HeLa cell extracts compared to the linear form of the streptavidin aptamer. The self-spliced circular RNA from the transcribed permuted intron-exon transcripts in E. coli cells was purified from a total RNA fraction using the solid-phase DNA probe method following anion exchange chromatography that excluded gel electrophoresis. This study provides an alternative method for designing and purifying useful RNA aptamers.

KW - Circular RNA aptamer

KW - In vivo expression

KW - Self-splicing

KW - Solid-phase DNA probe method

UR - http://www.scopus.com/inward/record.url?scp=60549105176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60549105176&partnerID=8YFLogxK

U2 - 10.1016/j.jbiotec.2008.12.012

DO - 10.1016/j.jbiotec.2008.12.012

M3 - Article

VL - 139

SP - 265

EP - 272

JO - Journal of Biotechnology

JF - Journal of Biotechnology

SN - 0168-1656

IS - 4

ER -